Imfinzi

197,00 

Therapeutic PD-L1-antibody from the original commercial drug Imfinzi targeting the PD-L1-antigen, also referred to as Durvalumab antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Expiry date Availability Certificate of Analysis (CoA) PriceQuantityTotal
aliquot 50804AACY10/20213 wks No 197,00 
-
+
197,00 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Durvalumab

Antigen

PD-L1

Product Concentration [mg/mL]

50

Volume per Vial [µL]

80

Quantity per vial [mg]

4

Batch Number

AACY

Manufacturing Year

-, 2016

Expiry date

10/2021

Availability

3 wks

Certificate of Analysis (CoA)

Yes, No, n.a.

You may also like…